Home›Stock Screener›Cian Healthcare›Financial Statements

Cian Healthcare Complete Financial Statements

6 Years of Data
2025 - 2020

In FYNone, Cian Healthcare (CHCL) reported revenue ₹0 Cr, net profit ₹0 Cr and EPS ₹0.00, with a net profit margin of -83.9% and ROE of -81.3%. Full financial statements from FY2020 to FY2025 (6 years) — income statement, balance sheet and cash flow in ₹ Crores. Download as Excel or CSV. Explore Cian Healthcare intrinsic worth to estimate fundamental worth using multiple valuation models.

Complete Financial Data Export

Profitability Ratios

Net Profit Margin -83.87% 2025 data
EBITDA Margin -19.35% 2025 data
Operating Margin -22.00% 2025 data
Return on Assets -16.67% 2025 data
Return on Equity -81.25% 2025 data

Balance Sheet Ratios

Current Ratio 7.89 2025 data
Debt to Equity 4.88 2025 data
Equity Ratio 20.51% 2025 data
Asset Turnover 0.20 2025 data

CHCL Revenue, Net Profit & EBITDA — Year-on-Year Growth

CHCL YoY (March 2025 vs Period) — revenue -100.0%, net profit +100.0%, EBITDA +100.0%, expenses -100.0%. For live price, earnings ratios and company overview, see CHCL share price.

Revenue Growth
-100.0%
Year-over-Year
Net Profit Growth
+100.0%
Year-over-Year
EBITDA Growth
+100.0%
Year-over-Year
Expense Growth
-100.0%
Year-over-Year
Assets Growth
-3.1%
Year-over-Year
Equity Growth
-44.8%
Year-over-Year
Liabilities Growth
-3.1%
Year-over-Year
Operating Cash Flow Growth
+75.0%
Year-over-Year
Investing Cash Flow Growth
+100.0%
Year-over-Year
Financing Cash Flow Growth
+60.0%
Year-over-Year

CHCL Income Statement — Revenue, EBITDA & Net Profit

Cian Healthcare revenue ₹0 Cr, EBITDA ₹0 Cr, net profit ₹0 Cr, EPS ₹0.00 (None) — net profit margin -83.9%. Review CHCL P/E ratio to evaluate earnings-based valuation against sector peers.

Periods ₹ Crores
Particulars None March 2025 March 2024 March 2023 March 2022 March 2021 March 2020
Revenue 0 31 62 69 78 74 58
Expenses 0 38 51 56 74 62 50
EBITDA 0 -6 11 13 5 12 8
Operating Profit Margin % 0.00% -22.00% 18.00% 18.00% 5.00% 16.00% 13.00%
Depreciation 0 4 6 5 4 4 4
Interest 0 3 6 6 6 8 7
Profit Before Tax 0 -26 0 2 -6 1 -4
Tax 0 0 -1 0 -1 1 0
Net Profit 0 -26 1 2 -6 0 -4
Earnings Per Share (₹) 0.00 -10.39 0.34 0.81 -2.21 0.02 -1.62

CHCL Balance Sheet — Assets, Liabilities & Shareholders' Equity

CHCL total assets ₹156 Cr, total equity ₹32 Cr, total liabilities ₹156 Cr (2025) — ROE -81.3%.

Years Annual Data ₹ Crores
Particulars 2025 2024 2023 2022 2021 2020
ASSETS
Total Assets 156 161 161 166 157 157
Current Assets 71 72 74 79 63 54
Fixed Assets 35 39 45 50 37 39
Capital Work in Progress 15 15 14 13 26 25
Investments 0 0 0 0 0 5
Other Assets 106 107 102 103 95 87
LIABILITIES
Total Liabilities 156 161 161 166 157 157
Current Liabilities 9 37 38 41 41 50
Non-Current Liabilities
SHAREHOLDERS' EQUITY
Total Equity 32 58 58 56 58 58
Share Capital 25 25 25 25 23 23
Reserves & Surplus 7 33 33 31 35 35

CHCL Cash Flow Statement — Operating, Investing & Financing

Cian Healthcare operating cash flow ₹21 Cr, investing ₹0 Cr, financing ₹-4 Cr, net cash flow ₹17 Cr (2025).

Periods ₹ Crores
Particulars March 2025 March 2024 March 2023 March 2022 March 2021 March 2020
Operating Activities 21 12 5 9 6 -7
Investing Activities 0 -2 3 1 3 -27
Financing Activities -4 -10 -7 -11 -10 36
Net Cash Flow 17 0 0 -1 -1 1